The federal No Surprises Act (NSA) prevented more than 2 million surprise medical bills for the first two months of 2022 – far more than federal regulators initially estimated. If the trend continues, the law will block more than 12 million surprise bills to patients this year, according to a projection from AHIP and the […]
The absence of an established, repeatable, and scalable path to commercialization and prescription of DTx has bottlenecked broader uptake, says one physician leader. Key Takeaways The Centers for Medicare & Medicaid Services has repealed its Medicare Coverage of Innovative Technology final rule. The action leaves multiple unanswered questions for digital therapeutic reimbursement, with payers […]